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Reveals a Zinc-Binding Motif Unique to the Bacterial Enzyme†,‡
Patrick Bilder,§,| Sandra Lightle,⊥,| Graeme Bainbridge,⊥ Jeffrey Ohren,⊥ Barry Finzel,⊥ Fang Sun,⊥ Susan Holley,⊥
Loola Al-Kassim,⊥ Cindy Spessard,⊥ Michael Melnick,⊥ Marcia Newcomer,# and Grover L. Waldrop*,#
Department of Biological Sciences, Louisiana State UniVersity, Baton Rouge, Louisiana 70803, Department of Biochemistry,
Vanderbilt UniVersity School of Medicine, NashVille, Tennessee 37232, and Pfizer Global Research and DeVelopment,
Ann Arbor, Michigan 48105

Downloaded via LOUISIANA STATE UNIV on October 5, 2021 at 14:44:51 (UTC).
See https://pubs.acs.org/sharingguidelines for options on how to legitimately share published articles.

ReceiVed October 7, 2005; ReVised Manuscript ReceiVed December 6, 2005

ABSTRACT: Acetyl-coA carboxylase (ACC) is a central metabolic enzyme that catalyzes the committed
step in fatty acid biosynthesis: biotin-dependent conversion of acetyl-coA to malonyl-coA. The bacterial
carboxyltransferase (CT) subunit of ACC is a target for the design of novel therapeutics that combat
severe, hospital-acquired infections resistant to the established classes of frontline antimicrobials. Here,
we present the structures of the bacterial CT subunits from two prevalent nosocomial pathogens,
Staphylococcus aureus and Escherichia coli, at a resolution of 2.0 and 3.0 Å, respectively. Both structures
reveal a small, independent zinc-binding domain that lacks a complement in the primary sequence or
structure of the eukaryotic homologue.

According to the Centers for Disease Control and Prevention, the rates of severe, multidrug-resistant bacterial infections, including those caused by pathogens previously
confined to the hospital setting, have increased dramatically
in both hospital and community populations (1, 2). Both
Gram-positive [Staphylococcus aureus (Sa)1 and Streptococcus pneumoniae] and Gram-negative [Escherichia coli (Ec)
and Pseudomonas aeruginosa] bacteria have ultimately
developed resistance to successive generations of clinically
useful antibiotics. The severity of microbial resistance is
underscored by the recent emergence of vancomycin-resistant
clinical isolates of methicillin-resistant Sa, which are responsible for most of the severe hospital-acquired illnesses
(3-5). The ability to combat these organisms will therefore
require the development of pharmaceuticals against novel
cellular targets (6).
†
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Abbreviations: ACC, acetyl-CoA carboxylase; BCCP, biotinoyl
carboxyl carrier protein; BC, biotin carboxylase; CT, carboxyltransferase; PCC, propionyl-CoA carboxylase; ACP, acyl carrier protein;
Ps 12S, Propionibacterium shermanii 12S transcarboxylase; Sa, Staphylococcus aureus; Ec, Escherichia coli; Sco, Streptomyces coelicolor;
Sc, Saccharomyces cereVisiae; FAS II, bacterial type-II fatty acid
biosynthesis; KAS, ketoacyl-ACP synthase; MMCoA, methyl-malonyl
CoA; BiSA, bisubstrate analogue; HS, helical subdomain.

A subset of enzymes that catalyze bacterial type-II fatty
acid biosynthesis (FAS II), a pathway distinct from the
mammalian type-I system by virtue of its requirement for
de noVo fatty acid production and the structural divergence
of its key constituents, represent strong candidates for
antimicrobial drug design (7-9). Validation of the bacterial
FAS II system as a potential pathway for the selection of
novel targets is provided by anti-tubercular and broadspectrum antibacterial agents that selectively inhibit the
enoyl-ACP (acyl carrier protein) reductase-mediated reduction step of the FAS II elongation cycle (10-11). Additional
FAS-II-pathway antimicrobials block β ketoacyl-ACP synthase (KAS) enzymes responsible for fatty acid chain
condensation (12-15). However, the design of enoyl-ACP
reductase and KAS inhibitors across bacterial species is
complicated by the presence of orthologous enzymes with
multiple isoforms and/or variable substrate specificities (7).
In contrast, the widespread conservation of bacterial acetylCoA carboxylase (ACC), an essential enzyme that generates
the malonyl-CoA precursor required for the subsequent
condensation steps of de noVo fatty acid synthesis, suggests
that ACC is an attractive FAS-II-pathway target. The
potential for ACC as an antibiotic target is demonstrated by
the recent discovery of the antibiotic Moiramide B and its
derivatives, the pyrrolidinediones, as potent inhibitors of
ACC (16, 17). Unfortunately, Moiramide B is not useful
clinically. Other compounds, including several classes of
well-established herbicides, the aryloxyphenoxypropionates
and cyclohexanediones, and a synthetic bisubstrate analogue
(BiSA) represent additional ACC-selective inhibitors (18,
19).
An assembly of protein constituents is required for in ViVo
ACC activity: biotinoyl carboxyl carrier protein (BCCP),
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biotin carboxylase (BC), and carboxyltransferase (CT). These
components participate in the following partial reactions:
BC, Mg2+

HCO3- + ATP + BCCP-biotin {\}
BCCP-biotin-CO2 + ADP + Pi (1)
CT

BCCP-biotin-CO2 + acetyl-CoA {\}
malonyl-CoA + biotin (2)
The biotinylated mobile arm of BCCP shuttles the biotin
cofactor from the site of BC-mediated, ATP-dependent
carboxybiotin production (1) into the site of CT-mediated
CO2 transfer from carboxybiotin to acetyl-CoA (2). In
eubacteria, protozoa, and plant chloroplasts, ACC activity
arises from a multisubunit assembly (prokaryotic ACC) of
monomeric biotin-BCCP, dimeric BC, and heterotetrameric
(R2β2) CT. In contrast, in fungi, animals, and plant cytosol,
each of these subunits function as distinct domains within a
single polypeptide (eukaryotic ACC) (20, 21). The two-step
carboxylase reaction mechanism and the structural organization of the ACC multienzyme into distinct BC, BCCP, and
CT components is shared among members of the biotindependent enzyme family, including propionyl-CoA carboxylase, transcarboxylase, glutaconyl-CoA decarboxylase,
and methylcrotonyl-CoA carboxylase (22). The lack of
primary sequence conservation observed between the prokaryotic and eukaryotic forms of ACC and the major differences
in multi-enzyme subunit composition are features that can
potentially be exploited to inhibit specific partial reactions
of bacterial ACC without disruption of the mammalian
homologue.
Herein, we present the X-ray structures of the CT
component of bacterial ACC, a novel member of the
crotonase superfamily, from representative Gram-positive
(Sa) and Gram negative (Ec) species. Both structures possess
a unique zinc-binding domain that partially shelters the
acetyl-CoA binding site. This motif is conspicuously absent
in both the primary sequence of the eukaryotic enzyme and
the tertiary structure of the only eukaryotic ACC CT structure
(yeast) reported to date (23).
MATERIALS AND METHODS
Cloning, Expression, and Purification. The strategy for
overexpression of the genes coding for the R and β subunits
of Sa and Ec CT has been described by Blanchard and
Waldrop (24). Because the genes for the R and β subunits
are not contiguous on the genome, a mini-operon was
constructed to allow for overexpression of both genes.
Specifically, the genes corresponding to the R (residues
1-314) and β (residues 1-285) subunits of Sa CT were
PCR-amplified from genomic DNA, ligated into pDESTT7-202, and transformed into E. coli strain BL21-Gold
(DE3). After induction with 0.25 mM IPTG, expression was
carried out in a rich medium supplemented with 50 µg/mL
kanamycin at 20 °C for 20 h. A similar cloning protocol
was employed for the genes corresponding to the R (residues
1-319) and β (residues 1-304) of Ec CT, with the exception
that the genomic amplification products were ligated into
pET14b and transformed into strain BL21(DE3)pLysS. After
induction with 3.2 mM IPTG, expression of Ec CT was
carried out in a rich medium supplemented with 100 µg/mL

Biochemistry, Vol. 45, No. 6, 2006 1713
ampicillin and 34 µg/mL chloramphenicol at 20 °C for 15
h. In both cases, the cells were harvested by centrifugation
at 6722g for 30 min at 4 °C. The pellets were lysed by
freeze-thaw/resuspension in 50 mM Tris-Base at pH 8.0,
10 mM MgCl2, 500 mM NaCl, and 1% Triton X-100 and
passage through a microfluidizer. The lysate was centrifuged
at 11000g for 1 h, and the supernatant was loaded onto a
Ni-NTA resin (Qiagen) pre-equilibrated in 50 mM Tris-Base
at pH 8.0 and 500 mM NaCl (buffer A). The CT subunits
were eluted with a linear imidazole gradient from 0 to 200
mM in buffer A (Sa CT) or in a step to 200 mM imidazole
after a 20 mM imidazole wash (Ec CT). Eluted CT (assessed
by SDS-PAGE) was dialyzed overnight in 10 mM KH2PO4 at pH 7.0 and 0.67 mM EDTA, transferred for a second
dialysis in 10 mM HEPES at pH 7.0 and 500 mM NaCl the
following day, and purified to homogeneity with a Hi-Load
26/60 Superdex 200 (Amersham) column pre-equilibrated
with 25 mM HEPES at pH 7.5 and 500 mM NaCl. In the
case of Ec CT only, the gel-filtration step was preceded by
cleavage and removal of the His tag through thrombin
(Sigma) digestion and passage over a Hi-Trap (Pharmacia)
chelating column charged with NiSO4 in 25 mM HEPES,
500 mM NaCl, and 20 mM imidazole at pH 7.5. The protein
was subsequently concentrated to 15 mg/mL and stored in
aliquots at -80 °C prior to crystallization.
Crystallization. Sa CT or Ec CT (each at 15 mg/mL) were
cocrystallized with BiSA (1 mM) under condition A (30%
PEG-400, 0.1 M HEPES at pH 8.0, and 0.2 M MgCl2 at 25
°C) or condition B (1 M NaH2PO4, 1 M K2HPO4, 0.2 M
Li2SO4, and 0.1 M CAPS at pH 9.5 and 4 °C), respectively,
by the vapor diffusion method. The Sa CT condition
produced platelike crystals in 3-5 days. Hexagonal bipyramidal Ec CT crystals grew over a similar time interval
under condition B.
X-ray Data Collection. Prior to data collection, CT crystals
were flash-frozen in liquid nitrogen immediately after transfer
to a solution of 10% ethylene glycol in mother liquor (Sa
CT) or after slow, incremental transfer to 6.25, 12.5, and
25% ethylene glycol in reservoir solution (Ec CT). Complete
data sets for Sa CT and Ec CT were collected at 100 K to
1.98 and 3.2 Å, respectively, at the Industrial Macromolecular
Crystallography Association Collaborative Access Team
(IMCA-CAT) beam-line 17-ID at the Advanced Photon
Source (Argonne National Laboratory). All data were
processed with HKL2000 (38). Diffraction images were
processed and scaled using the Denzo/HKL suite (37). Data
collection statistics are shown in Table 1.
Structure Determination and Refinement. The structure of
Sa CT was solved by molecular replacement in CNS (39)
with a dimeric polyalanine search model derived from the
Ps 12S hexamer (PDB ID 1ON3, chains A and D). A
monomer of the search model corresponds to a tandem
domain repeat, and each of the structurally homologous
domains shares <15% sequence identity with the R and β
subunits of Sa CT. The search model (the dimer that
corresponds to a R2β2 tetramer) was positioned in the
asymmetric unit to give a correlation coefficient of two
standard deviations above the mean. Placement of a single
dimeric model is consistent with the noncrystallographic
symmetry of the Patterson and a Matthew’s coefficient (Vm
) 2.4 Å3/Da) in the generally observed range. After rigidbody, energy-minimization, and simulated-annealing refine-
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Table 1: X-ray Data Collection and Refinement Statistics
data collection
resolution range (Å)
total/unique reflections
completeness (%)
redundancy
I/σ
Rmerge (%)b
refinement
resolution range (Å)
number of reflections
σ cutoff
R factor (%)c
Rfree (%)d
number of refined atoms
protein
water
Zn2+
average B factors (Å2)
protein
water
Zn2+
overall
B from Wilson plot
rmsd
bonds (Å)
angles (deg)
Ramachandran plot
most favorable
additional allowed
disallowed (%)

Sa CT

Ec CT

50-1.98
273 345/90 018
98 (82)a
3.0 (2.7)
17.5 (3.4)
6.0 (29.3)

30-3.2
183 454/23 565
100 (100)
7.8 (8.0)
26.6 (4.1)
6.8 (41.2)

50-1.98
80 987
none
18.9
21.0

30-3.2
22 030
none
24.7
28.7

8689
583
2

4275
7
1

38.4
42.8
40.1
38.7
31.7

79.9
44.6
78.6
79.8
N/A

0.016
1.4

0.007
1.4

91.2
8.7
0.1

75.5
23.7
0.8e

a
Values in parentheses refer to the highest resolution shell. b Rmerge
) ∑hkl∑i|Ihkl - 〈I〉hkl|/∑hkl∑i〈I〉hkl, where Ihkl is the intensity measurement
for a given reflection and 〈I〉hkl is the average intensity for multiple
measurements of this reflection. c R factor ) ∑|Fo,hkl - Fc,hkl|/∑(Fo,hkl)
× 100, where Fo,hkl is the observed structure factor amplitude and Fc,hkl
is the calculated structure factor amplitude. d Rfree was calculated from
5% of the diffraction data and monitored throughout refinement.
e
Outliers observed in regions of poorly defined density.

ment in CNS (Rwork/Rfree ) 52/53) of the polyalanine model,
a σA-weighted, 2Fo - Fc electron-density map calculated
over the full resolution range (50-1.98 Å) revealed interpretable side-chain density for a number of conserved
residues in the central core of the model.
A noncrystallographic symmetry matrix, assigned with the
assumption that the monomer pseudo-2-fold of the 12S
search model corresponds to an Rβ dimer pseudo-2-fold in
the Sa CT tetramer, was used to calculate an averaged,
solvent-flattened electron-density map with DM (40) in CCP4
(41). The map revealed clear side-chain electron density at
or near the dimer interface. Automated chain tracing and
refinement with ARP-wARP (42) (CCP4) increased the
extent of an initial model (from 11 to 80% of the protein)
and resulted in an Rwork/Rfree of 20/26. After further cycles
of model building in O (43) and refinement in Refmac 5
(CCP4; 44) over the entire resolution range, the final model
of Sa CT has an Rwork/Rfree of 18.9/21.0 and consists of 92%
(1120/1224) of the full-length sequence, 2 Zn2+, and 583
waters (Table 1). The remaining 8% of Sa CT localizes to a
22-residue disordered stretch at the far N terminus of the β
subunit and to a 10-residue gap between solvent-exposed
helices at the N terminus of R. A simulated annealing
composite omit map calculated in CNS and contoured at 1σ
reveals additional nonprotein electron density in the active
site that we tentatively assign to an undetermined portion of
the BiSA inhibitor.

A molecular replacement strategy for Ec CT was subsequently initiated with a polyalanine search model derived
from the refined Sa CT structure. Dimeric and tetrameric
search models were tested in each of several possible
hexagonal space groups. A solution [using Molrep (CCP4)]
was obtained in P6522 (Vm ) 5.0 Å3/Da, 75% solvent) with
the Rβ dimer as a search model (45). In this space group,
crystallographic symmetry operators generate the biological
heterotetramer from a single Rβ dimer in the asymmetric
unit. One cycle of rigid-body, energy-minimization, and
simulated-annealing refinement in CNS produced a map with
interpretable side-chain density for approximately 80% of
the Ec CT primary sequence (Rwork/Rfree ) 42/46). In
conjunction with model building in O and overall isotropic
B-factor refinement in CNS, further cycles of energyminimization and simulated-annealing refinement were conducted until the Rfree decreased below 30%. At this stage,
seven water molecules were added and a final round of
B-group and simulated-annealing refinement was performed
(Table 1). The backbone trace of the final Ec CT model
(Rwork/Rfree ) 25/29) superposes well [root-mean-square
deviation (rmsd) ) 1 Å] with the Sa CT model and lacks
density in similar regions of the structure. There are
additional poorly defined stretches encompassing residues
88-98 and 234-238 of the β monomer.
X-ray Fluorescence Measurements. Single-crystal and
solution-state X-ray fluorescence data were collected at the
Protein Crystallography MAD and the Double Crystal
Monochromator beamlines, respectively, at the Center for
Advanced Microstructures and Devices (Baton Rouge, LA).
Fluorescence emission spectra were recorded over an incident
energy range of 9640-9680 eV on a single Sa CT crystal
grown as described above and frozen at 100 K in a
cryosolution of 20% ethylene glycol in mother liquor.
Dispersive fluorescence measurements at an excitation energy
of 10.5 keV were collected over an emission range of 1-20
keV at room temperature on a solution of apo Sa CT
concentrated to 50 mg/mL in 10 mM HEPES at pH 7.0 and
500 mM NaCl. Spectra were acquired on the empty sample
cuvette under identical conditions as a control for background
emission from trace elements.
RESULTS AND DISCUSSION
OVerall Fold. The crystal structures of the carboxyltransferase components of acetyl-CoA carboxylase from Sa and
Ec were solved to resolutions of 2.0 and 3.2 Å, respectively.
Both structures confirm the R2β2 heterotetrameric assembly
determined by gel-filtration and sedimentation equilibrium
analysis of the purified Ec enzyme (25). The bacterial CT’s
share 52% sequence identity, and the tetramers superimpose
with a rmsd of 1 Å over 93% of the backbone trace (unless
otherwise noted, the Ec residue numbering employed throughout the text refers to residues conserved between both
species). The overall structure of the tetramer is a truncated
rectangular pyramid with its base at 72 × 88 Å, apex at 23
× 34 Å, and height at 52 Å (parts a, b, and d of Figure 1).
The oligomer is a dimer of dimers related by a 2-fold axis
that runs through a central cavity that gradually narrows from
a 13 Å diameter opening to a solvent-inaccessible surface
at a depth of 23 Å. Two distinct interfaces are generated by
structurally homologous, wedge-shaped R and β monomers
that occupy roughly equivalent volumes at the four corners
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FIGURE 1: Overall fold of Sa CT. (a) Stereo ribbon representation of the R2β2 heterotetramer. The R and β monomers are colored in green
and purple, respectively. (b) Schematic representation of the R2β2 heterotetramer in a as a truncated rectangular pyramid viewed from
above. The markings - - - and ‚‚‚ indicate the position of the “weak” and “strong” Rβ tetramer interfaces, respectively. The annotation ‚‚‚
also indicates a field out of direct view. (c and d) Perspective along the “weak” Rβ interface in which the tetramer in a and the tetramer
schematic in b have been rotated 90° about the x axis (see large dotted arrow), respectively. The Rβ dimer, which lies behind this Rβ face
has been removed for clarity. (e and f) Perspective along the “strong” Rβ interface in which the tetramer in c and the tetramer schematic
in d has been rotated 90° about the y axis (see small dotted arrows), respectively. The Rβ dimer, which lies behind this Rβ face has been
removed for clarity. a, c, and e were produced in Molmol (46) and rendered in Povray (47). These programs were used to create all ribbon
displays presented in this paper.

of the pyramid (parts a and b of Figure 1). The first consists
of a “weak” Rβ interface (∼4000 Å2 of buried surface)
situated on the vertical plane bisecting the short axes of the
pyramid (parts c and d of Figure 1). The second entails a
“strong” Rβ interface (∼9000 Å2 of buried surface) in which
the triangular faces of the monomers are juxtaposed on a
60° incline (parts e and f of Figure 1).

The structurally similar R and β monomers (A and B)
possess an R/β spiral core composed of a long, twisted, and
tapered 7-stranded mixed β sheet (Aβ1-5/Bβ5-9, Aβ6/
Bβ11, and Aβ8/Bβ13) orthogonal to a short, 2-stranded
parallel β platform (Aβ5/Bβ10 and Aβ7/Bβ12) (Figure 2).
The 7-stranded β sheet is flanked by helical regions (AR12/
BR9 and AR4/BR2) and a 3-helix bundle of AR6/BR4, AR7/
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FIGURE 2: Structure of the Sa CT R and β monomers and Rβ dimer. Schematic drawing in stereo of the structure of (a) the R monomer
(residues 1-18 and 30-314), (b) the β monomer (residues 26-285), and (c) the Rβ dimer. The secondary structural elements are labeled.
In the text, these labels are appended with “A” (representing the R monomer) or “B” (representing the β monomer).

BR5, and AR8/BR6. These helical elements constitute
pseudosymmetrical edges of the triangular face of the wedge.
Both sets of helices converge toward the apex of this triangle,
and the 3-helix bundle provides the primary scaffold for the
2-stranded platform at its base. The structure-based sequence
alignment in Figure 3 highlights (1) the extensive structural
homology of the spiral R/β monomer fold to enoyl-CoA
hydratase (crotonase) and (2) the presence of an oxyanion
hole (G204-G205) for CoA-thioenolate stabilization as
described for other members of the crotonase superfamily.

Both of these elements, which are maintained through
divergent evolution, place the bacterial CT subunits into this
enzyme subcategory (26). This classification was originally
predicted by Murzin on the basis of sequence alignments
(27).
The ActiVe Site. A “ridges in grooves”-type stacking of
conserved hydrophobic residues between the AR7-8 (I181,
L185, and L209) and BR5-6 (L174, M177, and A208)
helices generates a 6-helix bundle at the “strong” Rβ interface
(Figure 4). This packing arrangement orients the triangular

Crystal Structure of Carboxyltransferase
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FIGURE 3: Structure-based sequence alignment of Ec and Sa CT R/β monomers with Sco CT domains and crotonase. Color coding of
sequences: Ec/Sa R (light green), Sco domain 1 (dark green), Ec/Sa β (light purple), Sco domain 2 (dark purple), and crotonase (blue).
Sequences are numbered according to the Ec R/β monomers, and secondary structural elements corresponding to the Sa R/β monomers
(above the alignment) or crotonase (below the alignment) are color-coded according to the scheme employed for the Sa/Ec monomer or
crotonase sequences. Secondary structural elements within the structurally homologous spiral core domains of Sa/Ec monomers, and crotonase
is surrounded by a bold solid line. Within this outline, residues that constitute the conserved oxyanion holes that recognize the biotin ureido
enolate or CoA thioenolate intermediates are boxed in black. The invariant cysteinyl zinc ligands in CT β are boxed in red. Residues in Ec
R (22-38, 41, 46, and 52-53) and Ec β (93-98 and 285-204) that are not visible or lack clear side-chain density are absent or modeled
as alanine, respectively. This figure was produced using STRAP (48) and Alscript (49).

faces of dimer partners on a 60° tilt with respect to one
another and effectively doubles the length of the β-strand
platform by positioning the hairpins from individual mono-

mers on opposite sides of a pseudo-2-fold axis (Figure 4).
Because conserved residues found on and surrounding this
platform are located in the liganded active sites of other

1718 Biochemistry, Vol. 45, No. 6, 2006
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FIGURE 4: Structure of the Sa CT Rβ catalytic dimer. Ribbon representation of the complex between the R (green) and β (purple) monomers
along the “strong” interface. The pseudo-2-fold equivalent helices or strands that generate the 6 helix bundle or catalytic platform, respectively,
are labeled in orange in R and cyan in β. The annotation - - - indicates the helices encompassed by HS1, and the annotation ‚‚‚ indicates
the interdomain tilt angle. The inset is a schematic diagram of the ribbon representation.

FIGURE 5: Pseudo-2-fold Sa CT active-site platform in the Rβ catalytic dimer. The interlocking R (green) and β (purple) monomers as
viewed from a perspective above the catalytic platform. Centrally located, secondary structural elements that create the pseudo-2-fold
through the active site are colored in orange in R and cyan in β. The acetyl-CoA substrate and biocytin product are modeled in the active
site on the basis of the superposition with the Sco CT structure (28). Access/exit routes for substrates/products in the CT reaction are
labeled as GAPS A, B, and C.

Crystal Structure of Carboxyltransferase
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FIGURE 6: Sa CT active site. A stereo representation of a composite omit 2Fo - Fc electron-density map (violet) contoured at 1σ and
calculated for the refined Sa CT model in the region of the central pseudo-2-fold of the active site. Residue labels corresponding to amino
acids from Sa CT R and β are colored black and green, respectively. Centrally positioned, nonprotein electron density ascribed to BiSA is
proposed to interfere with acetyl-CoA access to the G207-G208 oxyanion hole of CT β.

FIGURE 7: Sa CT binds zinc with an atypical zinc ribbon motif. (a) X-ray fluorescence scan of a single Sa CT crystal reveals the characteristic
Zn K-edge profile. (b) Dispersive X-ray fluorescence spectra of a cuvette blank (red solid line) and solution-state Sa CT as purified (black
solid line) show a clear peak at the Zn K-edge. (c) Side-by-side ribbon representations of the Zn ribbon motif of Sa CT-β and the “classical”
Zn ribbon from the 50S ribosomal protein L37Ae of the halophilic archaebacterium Haloarcula marismortui.

biotin-dependent carboxylases, including the substrate-binding clefts of Streptomyces coelicolor (Sco)/Saccharomyces
cereVisiae (Sc) CT (23, 28) and Propionibacterium shermanii
12S transcarboxylase (Ps 12S) (29), we will henceforth refer
to this site as the “catalytic platform” (Figure 4).
The structurally equivalent overall folds of the R and β
subunits suggest duplication and divergence of a single
ancestral CT subunit gene. However, an inherent asymmetry
in the structural homology of the R and β subunits allows
for the creation of distinct biotin and acetyl-CoA-specific
subsites. When viewed from a perspective above the Rβ

interface, the R and β subunits possess structurally disparate
motifs that project toward the viewer. As shown in Figure
4, four subdomains [2 helical domains from the R subunit
(designated helical subdomain (HS) 1R and 2R (ΗS1R and
HS2R) and a Zn-binding domain and helical domain from
the β monomer (HS1β)] coalesce to provide a canopy over
the catalytic platform where three portals (labeled gaps A,
B, and C in Figure 5) in the canopy appear to provide activesite access. The regions that flank these portals break the
symmetry of the active site that would result if the structural
homology of the R or β subunits extended over the entire
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FIGURE 8: Sa/Ec CT active site presents a markedly electropositive surface by comparison to other CT structures. Electrostatic surface
renderings for the Sa/Ec CT tetramers and the Sco/Sc CT dimers are contoured from -5 (red) to 0 (white) to +5 (blue) kT/E. Only one of
the two pseudosymmetrically related active sites is indicated for each structure. Electrostatic potentials were calculated using Grasp (50)
and surface-mapped and rendered in VMD (51).

protein. The portals may serve as “traffic control” elements
that coordinate active-site access for substrates constrained
by bulky carrier groups: biotinoyl carboxyl carrier protein
and coenzyme A.
Two key conserved residues in the active site, G206 and
G207, are located in the consensus sequence 206-GGXXHHH-212 (where X ) a small residue, H ) hydrophobic),
which is at the N terminus of AR8 (Figure 3). The peptidic
hydrogens of G206 and G207 form a conserved oxyanion
hole at the base of this helix that is proposed to stabilize a
ureido enolate that forms during decarboxylation of carboxybiotin N1 in the homologous CT subunit of propionylCoA carboxylase (PCC) from Sco (28). Similarly, a conserved oxyanion hole in the β subunit is formed by G204
and G205 at the N terminus of BR6 (Figure 3). The peptidic
hydrogens of this glycine pair in the Sco PCC structure,
which correspond to the conserved oxyanion hole in crotonase, were found to act as hydrogen-bond donors to the
carbonyl of the methyl-malonyl-CoA (MMCoA) ligand and
proposed to stabilize the developing negative charge on the
enolate intermediate (28).
It is important to note that Sa CT was crystallized in the
presence of a BiSA inhibitor that combines features of both
substrates: coenzyme A is covalently linked to carboxybiotin
(19). However, continuous electron density consistent with
the intact inhibitor is not apparent (Figure 6). This absence
of density could be a consequence of hydrolysis of the
analogue in the course of the crystallization or could simply

reflect a lack of specific contacts over the length of the
inhibitor in our crystallization conditions. Inspection of a 2Fo
- Fc composite omit map reveals nonprotein density that
likely corresponds to a portion of the inhibitor in a
hydrophobic region of the active site at the central pseudo2-fold of the catalytic platform (Figure 6). In the structure
of MMCoA/biocytin-bound Sco PCC, a biotin-dependent
carboxyltransferase whose acyl-CoA substrate differs from
acetyl-CoA by the addition of a methyl group, the position
of the acyl thioester of MMCoA is in close proximity to the
density that we tentatively attribute to the BiSA inhibitor.
This density predominantly covers the hydrophobic cavity
that presents the helical dipole and oxyanion hole (G207G208 of BR6 in Sa CT) to the acyl thioester of MMCoA.
Mutations in Sa or Ec CT that confer resistance to the
pyrollidine dione derivative CPD2 (16) localize to two highly
conserved residues that are either nearby (G203A in Sa CTR)
or within (S207Y in Ec CTβ) consensus sequences that
define this oxyanion hole.
The Zn Domain: A Unique Feature of the Prokaryotic
Enzyme. While the overall fold of bacterial CT confirms that
it is indeed a member of the crotonase superfamily, a
surprising and novel feature of the enzyme is the Zn domain
(Figure 7c). Early Fo - Fc maps calculated for the Sa CT
structure revealed a 20σ peak encapsulated by a tetrahedral
arrangement of sulfurs contributed by the cysteine residues
that terminate Bβ1(C27)/Bβ3(C46) and those immediately
preceding Bβ2(C30)/Bβ4(C49) (Figure 3). X-ray fluores-
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cence spectra collected on solution-state and crystalline
preparations of Sa CT in its apo form demonstrate that the
peak corresponds to Zn2+ (parts a and b of Figure 7).
Sequence alignment of the CT β primary sequence with
orthologous enzymes from eubacteria, algae, plants, and
animals reveals that the cysteine ligands are invariant residues
within an independent N-terminal domain that exists in
prokaryotic but not eukaryotic CT. The Zn motif in CT β is
an atypical Cys4 “zinc ribbon” that most closely resembles
the Zn-binding structures observed in ribosomal proteins
(Figure 7c; PDB code 1jj2), RNA polymerase II subunits
(1i5b) and the basal transcription factors TFIIS(1tfi) and
TFIIB(1pft). Unlike the classical motif in which the second
sheet is three-stranded and significantly longer than the first
(30), the fold in CT β bears an intervening helix between
two short β hairpins (Figure 7c).
The inner face of the CT β Zn-binding domain forms
roughly half of an electropositive, hemicircular surface that
encompasses residues from both subunits (Figure 8). A
comparison of the electrostatic properties of Ec/Sa CT with
the structurally homologous carboxyltransferases Sc CT and
Sco PCCB reveals that Ec/Sa CT possess a greater overall
net positive charge at pH 7 (Ec CT ) +4, Sa CT ) -16, Sc
CT ) -26, and Sco CT ) -42). Zn domains are commonly
associated with DNA-binding proteins, and preliminary
studies using electrophoretic mobility shift assays indicate
that Ec CT does indeed bind DNA (data not shown). Studies
to determine the DNA-binding specificity of Ec CT, if any,
are underway.
In addition to nucleic-acid-binding functions, Zn ribbon
structures have also been found to constitute catalytically
essential, active-site “lids” in isoleucyl-tRNA synthetase,
methionyl-tRNA synthetase, and the histone deacetylase
silent information regulator 2 (31-35). In this regard, it is
noteworthy that the β subunit of the prokaryotic R2β2 CT
heterotetramer isolated from plant chloroplast, which aligns
over the primary sequence of both bacterial CT subunits
(39%/47% identity between pea and Ec CT-β/R), bears the
zinc finger consensus C-X2-C-X15-C-X2-C (35). Deletion of the Zn finger motif in plastidic CT completely
abrogates enzymatic activity, while mutagenesis of the four
individual cysteines to alanine produces an enzyme that
exhibits <20% wild-type activity (36). Because phylogenetic
evidence indicates that plastidic ACC subunit genes are
derived from a cyanobacterial endosymbiont and the site of
plant lipid biosynthesis resides within the choroplast, these
observations suggest the possibility that the prokaryotic CT
Zn domain participates in a conserved activity related to fatty
acid synthesis initiation (37).
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program for display and analysis of macromolecular structures,
J. Mol. Graphics 14, 51-55.
47. POVRAY, http:/www.povray.org/.
48. Gille, C., and Frommel, C. (2001) STRAP: Editor for structural
alignments of proteins, Bioinformatics 17, 377-378.
49. Barton, G. J. (1993) ALSCRIPT: A tool to format multiple
sequence alignments, Protein Eng. 6, 37-40.
50. Nicholls A., Sharp K., and Honig B. (1991) Proteins: Struct.,
Funct., Genet. 11, 281ff.
51. Humphrey, W., Dalke, A., and Schulten, K. (1996) VMDsVisual
molecular dynamics, J. Mol. Graphics 14, 33-38.
BI0520479

